CN Stock MarketDetailed Quotes

688098 Shanghai Shen Lian Biomedical Corporation

Watchlist
  • 5.28
  • -0.08-1.49%
Market Closed Apr 30 15:00 CST
2.17BMarket Cap160.00P/E (TTM)

Shanghai Shen Lian Biomedical Corporation Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
-10.77%40.94M
-14.73%44.98M
54.11%39.01M
130.91%148.84M
-13.51%45.88M
19.29%52.74M
-69.53%25.31M
-64.26%64.46M
-49.14%53.05M
-61.42%44.21M
Transactional financial assets
-50.46%132.32M
-46.78%162.38M
-51.65%144.68M
-69.30%90.45M
-24.72%267.09M
-28.05%305.12M
-15.93%299.22M
-0.35%294.66M
-13.52%354.8M
-10.24%424.08M
Notes receivable and accounts receivable
17.12%313.4M
22.99%273.97M
8.15%325.35M
31.55%257.29M
21.71%267.58M
44.07%222.76M
36.99%300.84M
24.06%195.58M
30.89%219.86M
17.75%154.61M
-Notes receivable
----
----
----
----
-98.68%33.12K
-83.20%604.82K
--2.52M
--1.92M
--2.5M
--3.6M
-Accounts receivable
17.14%313.4M
23.33%273.97M
9.06%325.35M
32.86%257.29M
23.09%267.55M
47.11%222.15M
35.84%298.31M
22.84%193.66M
29.40%217.36M
15.01%151.01M
Other receivables (including interest and dividends)
-22.78%4.83M
-54.71%3.09M
-42.02%3.86M
-64.62%3.07M
1.66%6.25M
13.68%6.82M
7.94%6.65M
34.92%8.68M
4.65%6.15M
65.21%5.99M
-Other receivable
----
-54.71%3.09M
----
-64.62%3.07M
----
13.68%6.82M
----
34.92%8.68M
----
65.21%5.99M
Advance payment
-36.72%1.8M
-23.64%2.09M
-7.68%4M
-8.14%6.2M
61.27%2.85M
139.96%2.74M
267.24%4.33M
583.62%6.75M
184.13%1.76M
67.98%1.14M
Inventories
1.04%112M
-3.07%111.79M
8.60%115.11M
0.10%121.18M
7.39%110.85M
11.51%115.33M
3.60%106M
70.78%121.06M
22.56%103.22M
45.31%103.42M
Other current assets
----
----
----
--637.79K
----
----
----
----
----
----
Total current assets
-13.59%605.3M
-15.20%598.29M
-14.87%632M
-9.19%627.66M
-5.19%700.5M
-3.81%705.5M
-3.37%742.35M
-2.93%691.19M
-4.45%738.84M
-7.61%733.46M
Non Current assets
Fixed assets
----
-2.79%658.33M
----
-4.52%659.7M
----
6.78%677.24M
----
16.01%690.96M
----
15.19%634.21M
Constru in process
----
65.18%163.44M
----
43.40%121.6M
----
-26.04%98.95M
----
-35.49%84.79M
----
45.16%133.78M
Productive biological assets
--197.1K
--206.46K
----
----
----
----
----
----
----
----
Intangible assets
99.97%104.56M
76.20%93.6M
182.83%95.37M
136.43%76.96M
60.91%52.29M
62.65%53.12M
3.55%33.72M
-0.72%32.55M
-1.54%32.5M
-1.70%32.66M
Development expenditure
-30.45%31.06M
0.44%42.35M
-27.10%40.97M
-12.98%38.42M
10.26%44.66M
18.70%42.17M
127.72%56.19M
166.81%44.15M
264.57%40.51M
1,784.98%35.52M
Deferred tax assets
-18.76%5.51M
-20.99%5.14M
-11.32%7.41M
-20.83%6.61M
-9.90%6.78M
-8.18%6.5M
-4.77%8.36M
-15.29%8.35M
-17.73%7.52M
-15.56%7.08M
Usufruct assets
-20.95%1.24M
182.92%1.33M
180.02%1.41M
201.18%1.49M
198.76%1.57M
-16.04%468.82K
-14.72%503.13K
-20.34%495.15K
--526.76K
-18.46%558.36K
Other non current assets
31.23%28.29M
51.96%29.72M
39.22%29.52M
-23.05%18.68M
11.13%21.56M
-0.29%19.56M
-39.81%21.21M
-5.44%24.27M
-56.04%19.4M
-40.17%19.62M
Total non current assets
9.91%988.85M
10.69%995.7M
8.99%979.38M
4.27%925.04M
2.76%899.67M
4.00%899.58M
6.38%898.63M
8.98%887.15M
15.53%875.48M
19.92%865M
Total assets
-0.38%1.59B
-0.69%1.59B
-1.80%1.61B
-1.62%1.55B
-0.88%1.6B
0.41%1.61B
1.73%1.64B
3.42%1.58B
5.44%1.61B
5.50%1.6B
Liabilities
Current liabilities
Notes payable and accounts payable
42.32%10.3M
-41.94%5.14M
-43.59%9.69M
-43.85%7.39M
-43.37%7.23M
-21.82%8.86M
5.07%17.17M
111.47%13.16M
149.32%12.78M
50.39%11.33M
-Accounts payable
42.32%10.3M
-41.94%5.14M
-43.59%9.69M
-43.85%7.39M
-43.37%7.23M
-21.82%8.86M
5.07%17.17M
111.47%13.16M
149.32%12.78M
50.39%11.33M
Contract liabilities
27.28%8.36M
-36.73%6.65M
-15.15%9.83M
-7.59%15.54M
132.14%6.57M
26.24%10.51M
-61.77%11.59M
-20.72%16.81M
-65.72%2.83M
-41.86%8.32M
Salaries payable
48.51%7.95M
-11.59%18.22M
-60.25%6.34M
-42.42%6.23M
-37.87%5.35M
-13.48%20.61M
-7.90%15.96M
-13.50%10.82M
-9.88%8.62M
-7.69%23.82M
Taxs payable
-46.88%5.03M
-82.11%2.35M
-69.42%7.54M
-93.77%818.63K
-41.56%9.47M
50.92%13.11M
90.87%24.64M
209.97%13.14M
42.08%16.2M
411.11%8.69M
Other payable (including interest and dividends)
10.52%38.21M
8.42%33.88M
0.20%32.96M
-14.51%26.76M
-23.72%34.58M
-29.63%31.25M
-10.44%32.9M
-23.36%31.3M
25.55%45.33M
21.07%44.41M
-Dividend payable
17.65%518.95K
17.65%518.95K
17.65%518.95K
705.15%3.55M
50.00%441.1K
50.00%441.1K
50.00%441.1K
50.00%441.1K
125.00%294.07K
125.00%294.07K
-Other payable
----
8.29%33.36M
----
-24.80%23.21M
----
-30.16%30.81M
----
-23.90%30.86M
----
20.69%44.11M
Non current liabilities due within one year
-5.36%329.87K
145.41%333.81K
150.21%345.91K
169.89%346.94K
167.90%348.56K
3.29%136.02K
3.74%138.25K
-4.67%128.55K
--130.11K
-4.67%131.69K
Other current liabilities
-14.85%9.9M
-22.06%9.93M
-10.90%11.84M
-45.44%9.65M
-33.16%11.63M
-24.27%12.74M
-35.11%13.29M
-19.24%17.68M
-13.07%17.4M
-15.20%16.83M
Total current liabilities
6.52%80.08M
-21.31%76.5M
-32.10%78.55M
-35.25%66.73M
-27.21%75.18M
-14.37%97.22M
-13.82%115.69M
-3.74%103.05M
14.17%103.29M
7.09%113.53M
Current liabilities
Long term account payable
----
----
----
----
----
----
----
--0
----
----
Specific account payable
----
----
----
----
----
----
----
--100K
----
----
Deferred tax liabilities
-98.40%10.73K
-94.44%17.88K
97.31%391.6K
-1.11%290.53K
93.65%669.38K
20.71%321.82K
45.70%198.47K
178.63%293.8K
772.38%345.67K
135.80%266.61K
Long term deferred income
-8.63%9.27M
-8.45%9.49M
-8.28%9.71M
-8.11%9.93M
-7.95%10.15M
-8.27%10.36M
-6.62%10.58M
-7.10%10.8M
-7.56%11.02M
-7.52%11.3M
Lease liabilities
-21.41%842.56K
195.92%917.19K
195.81%899.97K
178.73%985.8K
206.38%1.07M
-18.91%309.94K
-26.59%304.24K
-20.83%353.68K
--349.94K
-25.63%382.2K
Total non current liabilities
-14.84%10.12M
-5.21%10.42M
-1.67%11M
-3.00%11.2M
1.45%11.89M
-7.96%11M
-5.87%11.19M
-5.18%11.55M
-2.05%11.72M
-6.98%11.95M
Total liabilities
3.60%90.21M
-19.67%86.93M
-29.42%89.55M
-32.00%77.93M
-24.29%87.07M
-13.76%108.21M
-13.17%126.88M
-3.89%114.6M
12.28%115M
5.57%125.48M
Shareholders equity
Paid-in capital
0.00%410.64M
0.00%410.64M
0.00%410.64M
0.00%410.64M
0.00%410.64M
0.00%410.64M
0.00%410.64M
0.23%410.64M
0.23%410.64M
0.23%410.64M
Capital reserve funds
-1.31%539.23M
-1.25%539.23M
-1.89%547.35M
-1.75%546.86M
-1.48%546.4M
-1.11%546.04M
-0.46%557.91M
1.41%556.62M
1.89%554.59M
2.27%552.18M
Surplus reserve funds
4.75%75.02M
4.75%75.02M
8.61%71.62M
8.61%71.62M
8.61%71.62M
8.61%71.62M
21.39%65.94M
21.39%65.94M
21.39%65.94M
21.39%65.94M
Retained profit
-4.71%461.63M
-1.01%463.83M
-2.61%472.84M
2.11%445.65M
2.19%484.44M
4.10%468.57M
9.49%485.52M
10.23%436.44M
12.64%474.04M
14.68%450.11M
Shareholders equity without minority interests
-1.76%1.49B
-0.54%1.49B
-1.15%1.5B
0.35%1.47B
0.52%1.51B
1.22%1.5B
3.48%1.52B
4.31%1.47B
5.32%1.51B
5.90%1.48B
Minority interests
--17.42M
--18.34M
428.05%19.36M
----
----
----
-196.80%-5.9M
-196.39%-5.9M
-981.11%-5.89M
-3,906.56%-5.89M
Total shareholder equity
-0.61%1.5B
0.68%1.51B
0.51%1.52B
0.75%1.47B
0.92%1.51B
1.62%1.5B
3.22%1.51B
4.04%1.46B
4.95%1.5B
5.49%1.47B
Total liabilityies and equity
-0.38%1.59B
-0.69%1.59B
-1.80%1.61B
-1.62%1.55B
-0.88%1.6B
0.41%1.61B
1.73%1.64B
3.42%1.58B
5.44%1.61B
5.50%1.6B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
--
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds -10.77%40.94M-14.73%44.98M54.11%39.01M130.91%148.84M-13.51%45.88M19.29%52.74M-69.53%25.31M-64.26%64.46M-49.14%53.05M-61.42%44.21M
Transactional financial assets -50.46%132.32M-46.78%162.38M-51.65%144.68M-69.30%90.45M-24.72%267.09M-28.05%305.12M-15.93%299.22M-0.35%294.66M-13.52%354.8M-10.24%424.08M
Notes receivable and accounts receivable 17.12%313.4M22.99%273.97M8.15%325.35M31.55%257.29M21.71%267.58M44.07%222.76M36.99%300.84M24.06%195.58M30.89%219.86M17.75%154.61M
-Notes receivable -----------------98.68%33.12K-83.20%604.82K--2.52M--1.92M--2.5M--3.6M
-Accounts receivable 17.14%313.4M23.33%273.97M9.06%325.35M32.86%257.29M23.09%267.55M47.11%222.15M35.84%298.31M22.84%193.66M29.40%217.36M15.01%151.01M
Other receivables (including interest and dividends) -22.78%4.83M-54.71%3.09M-42.02%3.86M-64.62%3.07M1.66%6.25M13.68%6.82M7.94%6.65M34.92%8.68M4.65%6.15M65.21%5.99M
-Other receivable -----54.71%3.09M-----64.62%3.07M----13.68%6.82M----34.92%8.68M----65.21%5.99M
Advance payment -36.72%1.8M-23.64%2.09M-7.68%4M-8.14%6.2M61.27%2.85M139.96%2.74M267.24%4.33M583.62%6.75M184.13%1.76M67.98%1.14M
Inventories 1.04%112M-3.07%111.79M8.60%115.11M0.10%121.18M7.39%110.85M11.51%115.33M3.60%106M70.78%121.06M22.56%103.22M45.31%103.42M
Other current assets --------------637.79K------------------------
Total current assets -13.59%605.3M-15.20%598.29M-14.87%632M-9.19%627.66M-5.19%700.5M-3.81%705.5M-3.37%742.35M-2.93%691.19M-4.45%738.84M-7.61%733.46M
Non Current assets
Fixed assets -----2.79%658.33M-----4.52%659.7M----6.78%677.24M----16.01%690.96M----15.19%634.21M
Constru in process ----65.18%163.44M----43.40%121.6M-----26.04%98.95M-----35.49%84.79M----45.16%133.78M
Productive biological assets --197.1K--206.46K--------------------------------
Intangible assets 99.97%104.56M76.20%93.6M182.83%95.37M136.43%76.96M60.91%52.29M62.65%53.12M3.55%33.72M-0.72%32.55M-1.54%32.5M-1.70%32.66M
Development expenditure -30.45%31.06M0.44%42.35M-27.10%40.97M-12.98%38.42M10.26%44.66M18.70%42.17M127.72%56.19M166.81%44.15M264.57%40.51M1,784.98%35.52M
Deferred tax assets -18.76%5.51M-20.99%5.14M-11.32%7.41M-20.83%6.61M-9.90%6.78M-8.18%6.5M-4.77%8.36M-15.29%8.35M-17.73%7.52M-15.56%7.08M
Usufruct assets -20.95%1.24M182.92%1.33M180.02%1.41M201.18%1.49M198.76%1.57M-16.04%468.82K-14.72%503.13K-20.34%495.15K--526.76K-18.46%558.36K
Other non current assets 31.23%28.29M51.96%29.72M39.22%29.52M-23.05%18.68M11.13%21.56M-0.29%19.56M-39.81%21.21M-5.44%24.27M-56.04%19.4M-40.17%19.62M
Total non current assets 9.91%988.85M10.69%995.7M8.99%979.38M4.27%925.04M2.76%899.67M4.00%899.58M6.38%898.63M8.98%887.15M15.53%875.48M19.92%865M
Total assets -0.38%1.59B-0.69%1.59B-1.80%1.61B-1.62%1.55B-0.88%1.6B0.41%1.61B1.73%1.64B3.42%1.58B5.44%1.61B5.50%1.6B
Liabilities
Current liabilities
Notes payable and accounts payable 42.32%10.3M-41.94%5.14M-43.59%9.69M-43.85%7.39M-43.37%7.23M-21.82%8.86M5.07%17.17M111.47%13.16M149.32%12.78M50.39%11.33M
-Accounts payable 42.32%10.3M-41.94%5.14M-43.59%9.69M-43.85%7.39M-43.37%7.23M-21.82%8.86M5.07%17.17M111.47%13.16M149.32%12.78M50.39%11.33M
Contract liabilities 27.28%8.36M-36.73%6.65M-15.15%9.83M-7.59%15.54M132.14%6.57M26.24%10.51M-61.77%11.59M-20.72%16.81M-65.72%2.83M-41.86%8.32M
Salaries payable 48.51%7.95M-11.59%18.22M-60.25%6.34M-42.42%6.23M-37.87%5.35M-13.48%20.61M-7.90%15.96M-13.50%10.82M-9.88%8.62M-7.69%23.82M
Taxs payable -46.88%5.03M-82.11%2.35M-69.42%7.54M-93.77%818.63K-41.56%9.47M50.92%13.11M90.87%24.64M209.97%13.14M42.08%16.2M411.11%8.69M
Other payable (including interest and dividends) 10.52%38.21M8.42%33.88M0.20%32.96M-14.51%26.76M-23.72%34.58M-29.63%31.25M-10.44%32.9M-23.36%31.3M25.55%45.33M21.07%44.41M
-Dividend payable 17.65%518.95K17.65%518.95K17.65%518.95K705.15%3.55M50.00%441.1K50.00%441.1K50.00%441.1K50.00%441.1K125.00%294.07K125.00%294.07K
-Other payable ----8.29%33.36M-----24.80%23.21M-----30.16%30.81M-----23.90%30.86M----20.69%44.11M
Non current liabilities due within one year -5.36%329.87K145.41%333.81K150.21%345.91K169.89%346.94K167.90%348.56K3.29%136.02K3.74%138.25K-4.67%128.55K--130.11K-4.67%131.69K
Other current liabilities -14.85%9.9M-22.06%9.93M-10.90%11.84M-45.44%9.65M-33.16%11.63M-24.27%12.74M-35.11%13.29M-19.24%17.68M-13.07%17.4M-15.20%16.83M
Total current liabilities 6.52%80.08M-21.31%76.5M-32.10%78.55M-35.25%66.73M-27.21%75.18M-14.37%97.22M-13.82%115.69M-3.74%103.05M14.17%103.29M7.09%113.53M
Current liabilities
Long term account payable ------------------------------0--------
Specific account payable ------------------------------100K--------
Deferred tax liabilities -98.40%10.73K-94.44%17.88K97.31%391.6K-1.11%290.53K93.65%669.38K20.71%321.82K45.70%198.47K178.63%293.8K772.38%345.67K135.80%266.61K
Long term deferred income -8.63%9.27M-8.45%9.49M-8.28%9.71M-8.11%9.93M-7.95%10.15M-8.27%10.36M-6.62%10.58M-7.10%10.8M-7.56%11.02M-7.52%11.3M
Lease liabilities -21.41%842.56K195.92%917.19K195.81%899.97K178.73%985.8K206.38%1.07M-18.91%309.94K-26.59%304.24K-20.83%353.68K--349.94K-25.63%382.2K
Total non current liabilities -14.84%10.12M-5.21%10.42M-1.67%11M-3.00%11.2M1.45%11.89M-7.96%11M-5.87%11.19M-5.18%11.55M-2.05%11.72M-6.98%11.95M
Total liabilities 3.60%90.21M-19.67%86.93M-29.42%89.55M-32.00%77.93M-24.29%87.07M-13.76%108.21M-13.17%126.88M-3.89%114.6M12.28%115M5.57%125.48M
Shareholders equity
Paid-in capital 0.00%410.64M0.00%410.64M0.00%410.64M0.00%410.64M0.00%410.64M0.00%410.64M0.00%410.64M0.23%410.64M0.23%410.64M0.23%410.64M
Capital reserve funds -1.31%539.23M-1.25%539.23M-1.89%547.35M-1.75%546.86M-1.48%546.4M-1.11%546.04M-0.46%557.91M1.41%556.62M1.89%554.59M2.27%552.18M
Surplus reserve funds 4.75%75.02M4.75%75.02M8.61%71.62M8.61%71.62M8.61%71.62M8.61%71.62M21.39%65.94M21.39%65.94M21.39%65.94M21.39%65.94M
Retained profit -4.71%461.63M-1.01%463.83M-2.61%472.84M2.11%445.65M2.19%484.44M4.10%468.57M9.49%485.52M10.23%436.44M12.64%474.04M14.68%450.11M
Shareholders equity without minority interests -1.76%1.49B-0.54%1.49B-1.15%1.5B0.35%1.47B0.52%1.51B1.22%1.5B3.48%1.52B4.31%1.47B5.32%1.51B5.90%1.48B
Minority interests --17.42M--18.34M428.05%19.36M-------------196.80%-5.9M-196.39%-5.9M-981.11%-5.89M-3,906.56%-5.89M
Total shareholder equity -0.61%1.5B0.68%1.51B0.51%1.52B0.75%1.47B0.92%1.51B1.62%1.5B3.22%1.51B4.04%1.46B4.95%1.5B5.49%1.47B
Total liabilityies and equity -0.38%1.59B-0.69%1.59B-1.80%1.61B-1.62%1.55B-0.88%1.6B0.41%1.61B1.73%1.64B3.42%1.58B5.44%1.61B5.50%1.6B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----------Unqualified opinion--------
Auditor ----------Dahua Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg